Clinical Trials Logo

Filter by:
NCT ID: NCT03016975 Terminated - Clinical trials for Mitral Regurgitation

Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)

ACTIVE
Start date: June 1, 2017
Phase: N/A
Study type: Interventional

To establish the safety and effectiveness of the Edwards Cardioband System in patients with functional mitral regurgitation (FMR).

NCT ID: NCT03015961 Terminated - Clinical trials for Postoperative Pain Management

Phase 4, Controlled Study in Adult Subjects Undergoing Primary, 1-2 Level, Open Lumbar Spinal Fusion Surgery

Start date: February 21, 2017
Phase: Phase 4
Study type: Interventional

Primary Objective: The primary objective of this study is to compare postsurgical pain control following local infiltration analgesia (LIA) with EXPAREL admixed with bupivacaine HCl versus LIA with bupivacaine HCl in adult subjects undergoing open lumbar posterior spinal fusion surgery. Secondary Objectives: The secondary objectives of this study are to compare additional efficacy, safety, and health economic outcomes following LIA with EXPAREL admixed with bupivacaine HCl versus LIA with bupivacaine HCl in adult subjects undergoing open lumbar posterior spinal fusion surgery.

NCT ID: NCT03015792 Terminated - Clinical trials for Recurrent Plasma Cell Myeloma

Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant

Start date: March 10, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I/II trial studies the best dose and side effects of ibrutinib when given together with lenalidomide and dexamethasone and how well they work in treating patients with multiple myeloma that are not eligible for transplant. Ibrutinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving ibrutinib, lenalidomide, and dexamethasone may work better in treating patients with multiple myeloma.

NCT ID: NCT03014297 Terminated - Clinical trials for Neuroendocrine Tumors

Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression

Start date: March 6, 2017
Phase: Phase 1
Study type: Interventional

This is a single center, open label, phase I study involving grade I-III gastroenteropancreatic neuroendocrine tumors, consisting of a dose escalation Part A followed by an expansion cohort Part B. On Part A Patients will be treated with daily oral everolimus. Fosbretabulin will be administered IV either q3 weekly or q weekly based on PO CRM cohort. Part B: Once the investigators have established an MTD in Part A, the investigators will be treating 15 more patients at that dose combination. The primary and secondary objectives of the expansion cohort will be similar to Part A of the study, i.e., to establish a safety profile of the experimental drug combination and to collect and assess efficacy data. Patients will be treated with concurrent everolimus and fosbretabulin for 12 weeks.

NCT ID: NCT03013855 Terminated - Clinical trials for Fecal Immunochemical Test

Efficacy of Fecal Immunochemical Test Using Digital Rectal Exam

FIT-DRE
Start date: July 2016
Phase: Phase 1
Study type: Interventional

This study will investigate the use of digital rectal exam (DRE) to obtain stool samples for the fecal immunochemical test (FIT) in patients due for screening colonoscopy and in pre-operative patients with known colorectal cancer. FIT is currently FDA-approved for spontaneous stool and DRE, however, samples are not commonly obtained by DRE. In addition, some clinicians remain skeptical about the accuracy of FIT using stool obtained from DRE. This study aims to assess the correlation between FIT using the stool sample from DRE (FIT-DRE) and standard of care FIT (FIT-SOC). If good correlation is shown, the investigators may be able to demonstrate efficacy of FIT using a DRE in the clinic setting. This may help avoid logistical barriers, as well as improve compliance and adherence to colon cancer screening in the outpatient setting, eventually leading to improved quality of care.

NCT ID: NCT03013842 Terminated - Clinical trials for Pregnancy, Abdominal

Feasibility of a Non-invasive, Trans-abdominal, Low Cost Fetal Oximetry Probe on Pregnant Human Subjects

Start date: December 12, 2016
Phase: N/A
Study type: Interventional

Three non-invasive, trans-abdominal fetal oximetry probes will be tested on pregnant human subjects, in order to obtain fetal heart rate. We want to determine if this device can accurately measure a baby's oxygen level when placed on your abdomen. Current technology to measure a baby's oxygen levels requires a probe to be inserted into the vagina.

NCT ID: NCT03013192 Terminated - Clinical trials for Rotator Cuff Tendinopathy

Three Month Automated Messaging Intervention

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Patients who are prescribed physical therapy exercises for their shoulder will have increased compliance to their PT exercises, an increased ASES score, and will have increased range of motion (or reach maximum range of motion earlier) at the end of the 3 month EpxPhysicalTherapy intervention.

NCT ID: NCT03012282 Terminated - Clinical trials for Pancreatic Ductal Adenocarcinoma

CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer

Start date: June 22, 2017
Phase: N/A
Study type: Interventional

This pilot clinical trial studies how well computed tomography (CT) perfusion images work in assessing treatment response in patients with pancreatic cancer. Analyzing specific measurements on the CT perfusion images may help doctors better determine how a tumor responds to chemotherapy and/or radiation therapy and may help guide treatment for patients with pancreatic cancer.

NCT ID: NCT03011645 Terminated - Clinical trials for Cardiovascular Diseases

Gene-by-Stress Interactions in Intervention Studies Significance

Start date: May 24, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to identify gene variants that increase risk of cardiovascular disease (CVD) and type 2 diabetes, particularly genes related to stress factors.

NCT ID: NCT03011307 Terminated - Postoperative Pain Clinical Trials

Efficacy of Intrathecal Oxytocin to Speed Recovery After Hip Surgery

Start date: January 12, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effect of intrathecal oxytocin on speed of reduction in pain for the first 60 days after hip surgery.